Abstract |
Celia's encephalopathy (progressive encephalopathy with/without lipodystrophy, PELD) is a recessive neurodegenerative disease that is fatal in childhood. It is caused by a c.985C>T variant in the BSCL2/seipin gene that results in an aberrant seipin protein. We evaluated neurological development before and during treatment with human recombinant leptin ( metreleptin) plus a dietary intervention rich in polyunsaturated fatty acids (PUFA) in the only living patient. A 7 years and 10 months old girl affected by PELD was treated at age 3 years with metreleptin, adding at age 6 omega-3 fatty acid supplementation. Her mental age was evaluated using the Battelle Developmental Inventory Screening Test (BDI), and brain PET/MRI was performed before treatment and at age 5, 6.5, and 7.5 years. At age 7.5 years, the girl remains alive and leads a normal life for her mental age of 30 months, which increased by 4 months over the last 18 months according to BDI. PET images showed improved glucose uptake in the thalami, cerebellum, and brainstem. This patient showed a clear slowdown in neurological regression during leptin replacement plus a high PUFA diet. The aberrant BSCL2 transcript was overexpressed in SH-SY5Y cells and was treated with docosahexaenoic acid (200 µM) plus leptin (0.001 mg/ml) for 24 h. The relative expression of aberrant BSCL2 transcript was measured by qPCR. In vitro studies showed significant reduction (32%) in aberrant transcript expression. This therapeutic approach should be further studied in this devastating disease.
|
Authors | David Araújo-Vilar, Rosario Domingo-Jiménez, Álvaro Ruibal, Pablo Aguiar, Salvador Ibáñez-Micó, Miguel Garrido-Pumar, Miguel Ángel Martínez-Olmos, Concepción López-Soler, Cristina Guillín-Amarelle, María González-Rodríguez, Antonio Rodríguez-Núñez, Julián Álvarez-Escudero, Mercedes Liñares-Paz, Blanca González-Méndez, Silvia Rodríguez-García, Sofía Sánchez-Iglesias |
Journal | European journal of human genetics : EJHG
(Eur J Hum Genet)
Vol. 26
Issue 3
Pg. 396-406
(03 2018)
ISSN: 1476-5438 [Electronic] England |
PMID | 29367704
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- BSCL2 protein, human
- Fatty Acids, Unsaturated
- GTP-Binding Protein gamma Subunits
- Leptin
- metreleptin
|
Topics |
- Brain Diseases
(diet therapy, drug therapy, genetics)
- Cell Line, Tumor
- Child
- Diet
- Fatty Acids, Unsaturated
(administration & dosage, therapeutic use)
- Female
- GTP-Binding Protein gamma Subunits
(genetics, metabolism)
- Humans
- Leptin
(administration & dosage, analogs & derivatives, therapeutic use)
- Lipodystrophy
(diet therapy, drug therapy, genetics)
- Syndrome
|